Anti-IL17A (Cosentyx) (secukinumab biosimilar) mAb
Figure 1: Flow cytometry analysis with 1 μg/mL Anti-IL17A (secukinumab biosimilar) mAb (12-9156) on Expi293 cells transfected with Human IL17A protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
Roll over image to zoom in
Shipping Info:
Order now and get it on Wednesday November 27, 2024
Same day delivery FREE on San Diego area orders placed by 1.00 PM
| Amount : | 100 µg |
| Isotype : | IgG1 |
| Purification : | Purified from cell culture supernatant by affinity chromatography |
| Storage condition : | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature. |
| Alternative Name : | CTLA-8,CTLA8,IL-17,IL-17A,IL17 |
Secukinumab (Cosentyx) is a biologic medication used to treat psoriatic arthritis, moderate to severe plaque psoriasis. Biologics are medicines that are human-made through genetic engineering techniques and closely related to a protein that occurs naturally in the body. Secukinumab blocks an inflammatory protein called IL-17, thus improving joint pain and swelling from arthritis and rash from psoriasis.
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
